探索脂肪酸模拟物作为NR4A干
1Department of Pharmacy, Ludwig-Maximilians-Universität (LMU) München, 81377 Munich, Germany.
Journal of medicinal chemistry
|November 2, 2023
概括
研究人员发现了新的脂肪酸模拟 (FAM) 化合物,可以调节NR4A核受体. 这些新型FAM配体显示出对癌症和神经退行等疾病的治疗药物的潜力.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- NR4A核受体家族 (Nur77,Nurr1,NOR-1) 与神经退行和癌症有关.
- 对NR4A受体的药理调制对于目标验证至关重要,但缺乏足够的化学工具.
- 新兴证据表明NR4A受体与脂肪酸代谢产物和脂肪酸模仿药物 (FAM) 相互作用.
研究的目的:
- 为了探索FAM NR4A配体的化学空间.
- 为了确定NR4A受体调节的新化学支架.
- 开发针对NR4A通路的潜在治疗剂.
主要方法:
- 一个多样化的化学库 (92个碎片) 的碎片选.
- 在分析和系统结构-活动关系 (SAR) 评估.
- 优化已识别的FAM NR4A联体支架.
主要成果:
- 确定了11个新的FAM NR4A激动剂和逆激动剂支架.
- 在结构优化后发现了具有亚微分子强度和结合亲和力的有力NR4A激动剂.
- 证明FAM化合物是NR4A受体调节的可行工具.
结论:
- 脂肪酸模仿剂 (FAMs) 是开发NR4A受体调节器的一个有前途的化学品类.
- 优化的FAM配体具有作为NR4A相关病理的治疗药物的显著潜力.
- 这项研究扩大了针对NR4A向药物发现的工具包.
更多相关视频
04:48A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
Published on: July 10, 2018
9.3K
07:37Click-Chemistry Based Fluorometric Assay for Apolipoprotein N-acyltransferase from Enzyme Characterization to High-Throughput Screening
Published on: May 13, 2020
2.0K
相关概念视频
Transducer Mechanism: Nuclear Receptors
1.4K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.4K
Lipids as Anchors
5.6K
In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
5.6K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
1.1K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
1.1K
